All
- All
- Articles
- Calendar
- Compliance
- Newsletter
- Position Statements
- Press Release
- Regulatory
- Uncategorized
Overview of Homeopathic Drug Product Regulation
By J.P. Borneman, Chair, AAHP Legal and Regulatory Committee. The Homeopathic Pharmacopoeia Convention of the United States (HPCUS) is responsible for the publication of the...
Sen. Tom Harkin Honored for Safeguarding Americans’ Right to Choose Complementary Health Care
MILWAUKIE, Ore., March 27, 2013—Senator Tom Harkin (D-Iowa) was honored recently by the American Association of Homeopathic Pharmacists (AAHP) with an award of appreciation for...
When is a Homeopathic Product OTC or Rx ?
by Eric L. Foxman, R.Ph. Homeopathic drug products must meet stringent criteria for labeling and marketing. The specific criteria for Over-the-Counter (OTC) and Prescription drugs...
Quality Guidance for Homeopathic Manufacturers
Newton Square, PA, August 18, 2009 — The American Association of Homeopathic Pharmacists (AAHP) is reminding manufacturers of homeopathic drugs to take additional steps to...
FDA, FTC Actions On OTC HCG Weight-Loss Products
American Association of Homeopathic Pharmacists Supports FDA, FTC Actions to Remove OTC HCG Weight-Loss Products from the Market The American Association of Homeopathic Pharmacists (AAHP),...
Homeopathic Human Growth Hormone (HGH)
Position Statement from the American Association of Homeopathic Pharmacists regarding Homeopathic Human Growth Hormone (HGH) The appearance in natural foods stores and mass markets outlets...
Status of English vs. Latin Names of Homeopathic Ingredients
The following is the text of letter from FDA to the HPCUS regarding the use of Latin names on Homeopathic drug products. Department of Health...